Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3768114014 | Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3768115010 | Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3768116011 | Drospirenone- and ethinyl estradiol- and levomefolic acid-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3768117019 | Drospirenone- and ethinyl estradiol- and L-methylfolate-containing product in oral dose form | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3768118012 | Drospirenone- and ethinylestradiol- and L-methylfolate-containing product in oral dose form | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Plays role | Contraceptive therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Is a | Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Is a | Product containing levomefolic acid in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Is a | Product containing drospirenone and ethinylestradiol and levomefolic acid (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Has active ingredient | Drospirenone | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Has active ingredient | Levomefolic acid | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Has active ingredient | Ethinylestradiol | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Is a | True | Product containing drospirenone and ethinylestradiol and levomefolic acid in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR